CDER chief calls for ad­di­tion­al bud­get funds as staff de­par­tures spiked last sum­mer

When Pa­trizia Cavaz­zoni of­fi­cial­ly took the reins of FDA’s Cen­ter for Drug Eval­u­a­tion and Re­search last April, much of the at­ten­tion on her move to the top fo­cused on her rel­a­tive lack of ex­pe­ri­ence, hav­ing joined the agency in 2018.

But as Cavaz­zoni called to plug the gaps in CDER’s long-term bud­get pri­or­i­ties dur­ing an Al­liance for a Stronger FDA event on Mon­day, her com­fort in her rel­a­tive­ly new and in­creas­ing­ly dif­fi­cult po­si­tion was clear.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER